F-18-FDG uptake in breast cancer correlates with immunohistochemically defined subtypes

作者:Koo Hye Ryoung; Park Jeong Seon; Kang Keon Wook; Cho Nariya; Chang Jung Min; Bae Min Sun; Kim Won Hwa; Lee Su Hyun; Kim Mi Young; Kim Jin You; Seo Mirinae; Moon Woo Kyung*
来源:European Radiology, 2014, 24(3): 610-618.
DOI:10.1007/s00330-013-3037-1

摘要

Objectives To determine whether a correlation exists between maximum standardized uptake value (SUVmax) on F-18-fluorodeoxyglucose positron emission tomography (FDG-PET) and the subtypes of breast cancer. %26lt;br%26gt;Methods This retrospective study involved 548 patients (mean age 51.6 years, range 21-81 years) with 552 index breast cancers (mean size 2.57 cm, range 1.0-14.5 cm). The correlation between F-18-FDG uptake in PET/CT, expressed as SUVmax, and immunohistochemically defined subtypes (luminal A, luminal B, human epidermal growth factor receptor 2 (HER2) positive and triple negative) was analyzed. %26lt;br%26gt;Results The mean SUVmax value of the 552 tumours was 6.07 +/- 4.63 (range 0.9-32.8). The subtypes of the 552 tumours were 334 (60 %) luminal A, 66 (12 %) luminal B, 60 (11 %) HER2 positive and 92 (17 %) triple negative, for which the mean SUVmax values were 4.69+/-3.45, 6.51+/-4.18, 7.44+/-4.73 and 9.83+/-6.03, respectively. In a multivariate regression analysis, triple-negative and HER2-positive tumours had 1.67-fold (P %26lt; 0.001) and 1.27-fold (P = 0.009) higher SUVmax values, respectively, than luminal A tumours after adjustment for invasive tumour size, lymph node involvement status and histologic grade. %26lt;br%26gt;Conclusion FDG uptake was independently associated with subtypes of invasive breast cancer. Triple-negative and HER2-positive breast cancers showed higher SUVmax values than luminal A tumours. %26lt;br%26gt;Key Points %26lt;br%26gt;F-18-FDG PET demonstrates increased tissue glucose metabolism, a hallmark of cancers. %26lt;br%26gt;Immunohistochemically defined subtypes appear significantly associated with FDG uptake (expressed as SUVmax). %26lt;br%26gt;Triple-negative tumours had 1.67-fold higher SUVmax values than luminal A tumours. %26lt;br%26gt;HER2-positive tumours had 1.27-fold higher SUVmax values than luminal A tumours.

  • 出版日期2014-3